Troponin-I as a prognosticator of mortality in severe sepsis patients

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 270-275

  John, Jijo ^a   Woodward, D Bradley ^b   Wang, Yanping ^b   Yan, S Betty ^b   Fisher, Diana ^b   Kinasewitz, Gary T ^a   Heiselman, Darell ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Drotrecogin alfa (activated); PROWESS; Severe sepsis; Troponin

Indexed keywords

DROTRECOGIN; PLACEBO; PROTEIN C; TROPONIN I;

ADULT; AGE DISTRIBUTION; APACHE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEALTH STATUS; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL;

AGE FACTORS; ANTI-INFECTIVE AGENTS; APACHE; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; PROTEIN C; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; TROPONIN I;

EID: 77953322613     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.12.001     Document Type: Article

References (24)

1. McLean A.S., Huang S.J., Salter M. Bench-to bedside review: the value of cardiac biomarkers in the intensive care patient. Crit Care 2008, 12:215.
2. Collinson P., Gaze D. Cardiac troponins in intensive care. Crit Care 2005, 9:345-346.
3. Fromm R. Cardiac troponins in the intensive care unit: common causes of increased levels and interpretation. Crit Care Med 2007, 35:584-588.
4. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
5. Ammann P., Fehr T., Minder E.I., et al. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001, 27:965-969.
6. Arlati S., Brenna S., Prencipe L., et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med 2000, 26:31-37.
7. John J., Awab A., Norman D., et al. Activated protein C improves survival in severe sepsis patients with elevated troponin. Intensive Care Med 2007, 33:2122-2128.
8. Mannam P., Devarakonda V.S., Wittbrodt E.T., et al. Association of troponin I concentrations with outcomes in sepsis. Chest 2004, 865S:126.
9. Maeder M., Fehr T., Rickli H., et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006, 129:1349-1366.
10. Sands K.E., Bates D.W., Lanken P.N., et al. Academic Medical Center Consortium Sepsis Project Working Group. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 2007, 278:234-240.
11. Miniño A.M., Heron M.P., Murphy S.L., et al. Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Deaths: final data for 2004. Natl Vital Stat Rep 2007, 55:1-119.
12. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
13. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
14. Heiselman D.E., Woodward D.B., Wang Y., Fisher D.L., Kinasewitz G., John J. Troponin as a prognosticator of mortality in severe sepsis patients. Crit Care Med 2008, 36(12 Suppl):A160.
15. ver Elst K.M., Spapen H.D., Nguyen D.N., et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000, 46:650-657.
16. Ammann P., Maggiorini M., Bertel O., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003, 41:2004-2009.
17. Fernandes C.J., Akamine N., Knobel E. Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 1999, 25:1165-1168.
18. Spies C., Haude V., Fitzner R., et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113:1055-1063.
19. Turner A., Tsamitros M., Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999, 27:1775-1780.
20. Mehta N.J., Khan I.A., Gupta V., et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004, 95:13-17.
21. Scott E.C., Ho H.C., Yu M., et al. Pre-existing cardiac disease, troponin I elevation and mortality in patients with severe sepsis and septic shock. Anaesth Intensive Care 2008, 36:515-519.
22. Esmon C.T. The protein C pathway. Chest 2003, 124(3 Suppl):26S-32S.
23. Lim W., Qushmag I., Devereaux P.J., et al. Elevated cardiac troponin measurements in critically ill patients. Arch Inten Med 2006, 166:2446-2454.
24. Stein R., Gupta B., Agarwal S., et al. Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome. Am J Cardiol 2008, 102:509-512.